Roland Newman

5.3k total citations · 2 hit papers
69 papers, 4.3k citations indexed

About

Roland Newman is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Roland Newman has authored 69 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 34 papers in Radiology, Nuclear Medicine and Imaging and 22 papers in Immunology. Recurrent topics in Roland Newman's work include Monoclonal and Polyclonal Antibodies Research (34 papers), Glycosylation and Glycoproteins Research (24 papers) and T-cell and B-cell Immunology (8 papers). Roland Newman is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (34 papers), Glycosylation and Glycoproteins Research (24 papers) and T-cell and B-cell Immunology (8 papers). Roland Newman collaborates with scholars based in United States, United Kingdom and Germany. Roland Newman's co-authors include Melvyn F. Greaves, C. Schneider, Robert Sutherland, D. Robert Sutherland, D Delia, J. T. Kemshead, P. J. Klein, G. Uhlenbruck, Tucker W. LeBien and JH Kersey and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Roland Newman

68 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A one-step purification of membrane proteins using a high efficiency immunomatrix.

1982 705 citations Roland Newman et al. Journal of Biological Chemistry profile →
Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferrin.

1981 599 citations Robert Sutherland, Roland Newman et al. profile →

Peers

Countries citing papers authored by Roland Newman

Since Specialization

Citations

This map shows the geographic impact of Roland Newman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roland Newman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roland Newman more than expected).

Fields of papers citing papers by Roland Newman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roland Newman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roland Newman. The network helps show where Roland Newman may publish in the future.

Co-authorship network of co-authors of Roland Newman

This figure shows the co-authorship network connecting the top 25 collaborators of Roland Newman. A scholar is included among the top collaborators of Roland Newman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roland Newman. Roland Newman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Predictors of response and rational combinations for the novel MCL ‐1 inhibitor MIK665 in acute myeloid leukemia 2025 ·Molecular Oncology ·Joseph Saad, Roland Newman, (unknown), (unknown), Éric Durand, (unknown), Heikki Kuusanmäki, (unknown), Juho J. Miettinen, Komal Kumar Javarappa, (unknown), (unknown), Mika Kontro, Kimmo Porkka, Heiko Maacke, Janghee Woo, Ensar Halilovic, Caroline A. Heckman	1
2	A bispecific antibody that targets IL-6 receptor and IL-17A for the potential therapy of patients with autoimmune and inflammatory diseases 2018 ·Journal of Biological Chemistry ·Michael A. Lyman, (unknown), (unknown), Anjuli M. Timmer, Christine P. Stewart, Steve W. Granger, Richard Woods, Michela Silacci, Dragan Grabulovski, Roland Newman	24
3	CD154 Regulates Primate Humoral Immunity to Influenza 2003 ·American Journal of Transplantation ·James E. Crowe, Edith C. Sannella, Steffen Pfeiffer, George L. Zorn, Agnes M. Azimzadeh, Roland Newman, Geraldine G. Miller, Richard N. Pierson	25
4	A humanized anti-human CD154 monoclonal antibody blocks CD154–CD40 mediated human B cell activation 2001 ·International Immunopharmacology ·Peter Brams, Amelia Black, Eduardo A. Padlan, Kandasamy Hariharan, John E. Leonard, (unknown), Randolph J. Noelle, Roland Newman	36
5	Monotherapy with anti-CD40 ligand antibody (IDEC 131) for non-human primate allograft heart transplantation 2001 ·The Journal of Heart and Lung Transplantation ·(unknown), (unknown), (unknown), Jeffrey J. Atkinson, Roland Newman, Richard N. Pierson	16
6	Modification of the Fc Region of a Primatized IgG Antibody to Human CD4 Retains Its Ability to Modulate CD4 Receptors but Does Not Deplete CD4+ T Cells in Chimpanzees 2001 ·Clinical Immunology ·Roland Newman, Kandasamy Hariharan, Mitchell E. Reff, (unknown), Gary R. Braslawsky, (unknown), Nabil Hanna, Peter J. Bugelski, Michael Brigham‐Burke, Carl Crysler, Robert Gagnon, (unknown), Michael L. Doyle, Preston Hensley, Manjula Reddy, Raymond W. Sweet, Alemseged Truneh	45
7	Elimination of Fc Receptor-Dependent Effector Functions of a Modified IgG4 Monoclonal Antibody to Human CD4 2000 ·The Journal of Immunology ·Manjula Reddy, (unknown), Margery A. Chaikin, (unknown), Jacqueline Fishman‐Lobell, Ping Tsui, (unknown), Michael L. Doyle, Michael Brigham‐Burke, Darrell R. Anderson, Mitchell E. Reff, Roland Newman, Nabil Hanna, Raymond W. Sweet, Alemseged Truneh	97
8	Measurement of protein interaction bioenergetics: Application to structural variants of anti-sCD4 antibody 2000 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Michael L. Doyle, Michael Brigham‐Burke, Michael N. Blackburn, Ian Brooks, Thomas M. Smith, Roland Newman, Mitchell E. Reff, Walter F. Stafford, Raymond W. Sweet, Alemseged Truneh, Preston Hensley, Daniel J. O’Shannessy	15
9	Chimeric Human–Simian Anti-CD4 Antibodies Form Crystalline High Symmetry Particles 2000 ·Journal of Structural Biology ·Yu. G. Kuznetsov, John Day, Roland Newman, Alexander McPherson	15
10	High-performance capillary electrophoresis measurement of dolastatin-10 1997 ·Journal of Chromatography B ·(unknown), Roland Newman, (unknown), (unknown)	2
11	A PrimatizedMAb to Human CD4 Causes Receptor Modulation, without Marked Reduction in CD4+T Cells in Chimpanzees:In Vitroandin VivoCharacterization of a MAb (IDEC-CE9.1) to Human CD4 1997 ·Clinical Immunology and Immunopathology ·Darrell R. Anderson, (unknown), Nabil Hanna, John E. Leonard, Mitchell E. Reff, Roland Newman, (unknown), (unknown), Manjula Reddy, Raymond W. Sweet, Alemseged Truneh	25
12	Potentiation of murine MCa-4 carcinoma radioresponse by 9-amino-20(S)-camptothecin. 1997 ·PubMed ·Alexander Kirichenko, Tyvin A. Rich, Roland Newman, Elizabeth L. Travis	34
13	Myeloma Ig heavy chain V region sequences reveal prior antigenic selection and marked somatic mutation but no intraclonal diversity 1995 ·The Journal of Immunology ·Robert Vescio, Jiang Cao, (unknown), (unknown), Chun‐Hsin Wu, (unknown), Vin‐Cent Wu, Roland Newman, Alan Lichtenstein, James R. Berenson	112
14	“Primatization” of Recombinant Antibodies for Immunotherapy of Human Diseases: A Macaque/Human Chimeric Antibody Against Human CD4 1992 ·Nature Biotechnology ·Roland Newman, (unknown), Darrell R. Anderson, (unknown), (unknown), (unknown), (unknown), Mitchell E. Reff, Steve Shuey, Nabil Hanna	66
15	Structures of Miltenberger class I and II specific major human erythrocyte membrane sialoglycoproteins 1984 ·European Journal of Biochemistry ·W. Dahr, Roland Newman, Marcela Contreras, Maria Kordowicz, P. Teesdale, Konrad Beyreuther, Jürgen Krüger	33
16	Selection and properties of a mouse L-cell transformant expressing human transferrin receptor 1983 ·Nature ·Roland Newman, Derrick L. Domingo, Joseph Trotter, Ian S. Trowbridge	41
17	P-24: a human leukemia-associated and lymphohemopoietic progenitor cell surface structure identified with monoclonal antibody. 1981 ·The Journal of Experimental Medicine ·JH Kersey, Tucker W. LeBien, (unknown), Roland Newman, Robert Sutherland, M. F. Greaves	300
18	Binding of Peanut Lectin to Breast Epithelium, Human Carcinomas, and a Cultured Rat Mammary Stem Cell: Use of the Lectin as a Marker of Mammary Differentiation 1979 ·JNCI Journal of the National Cancer Institute ·Roland Newman, P. J. Klein, Philip S. Rudland	135
19	Further Studies on the Interaction of Lectins with Human Serum Glyeoproteins 1977 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·G. Uhlenbruck, Roland Newman, (unknown), H. G. Schwick	6
20	Alkali-labile oligosaccharides from glycoproteins of different erythrocyte and milk fat globule membranes 1976 ·Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis ·(unknown), Roland Newman, W. Dahr, G. Uhlenbruck	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact